Cargando…

Alteration of Cadherin 3 Expression and DNA Methylation in Association with Aggressive Renal Cell Carcinoma

Cadherins (calcium-dependent adhesion proteins) are important in cellular adhesion and may play a role in the development and progression of renal cell carcinoma (RCC). This study investigated changes in cadherin 3 (CDH3; P-cadherin) mRNA expression, DNA methylation, and protein expression in RCC an...

Descripción completa

Detalles Bibliográficos
Autores principales:	Faraj Tabrizi, Pouriya, Peters, Inga, Schimansky, Inga, Dubrowinskaja, Natalia, Reese, Christel, Tezval, Hossein, Kuczyk, Markus Antonius, Serth, Jürgen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10670999/ https://www.ncbi.nlm.nih.gov/pubmed/38003666 http://dx.doi.org/10.3390/ijms242216476

Ejemplares similares

DNA Methylation in INA, NHLH2, and THBS4 Is Associated with Metastatic Disease in Renal Cell Carcinoma
por: Katzendorn, Olga, et al.
Publicado: (2021)

DNA methylation of tumor associated calcium signal transducer 2 (TACSTD2) loci shows association with clinically aggressive renal cell cancers
por: Katzendorn, Olga, et al.
Publicado: (2021)

Tumor Specific Epigenetic Silencing of Corticotropin Releasing Hormone -Binding Protein in Renal Cell Carcinoma: Association of Hypermethylation and Metastasis
por: Tezval, Hossein, et al.
Publicado: (2016)

Age-, tumor-, and metastatic tissue-associated DNA hypermethylation of a T-box brain 1 locus in human kidney tissue
por: Serth, Jürgen, et al.
Publicado: (2020)

Neurofilament Heavy polypeptide CpG island methylation associates with prognosis of renal cell carcinoma and prediction of antivascular endothelial growth factor therapy response
por: Dubrowinskaja, Natalia, et al.
Publicado: (2014)

Comparison of PD-L1 Scores in Primary Kidney Tumors Versus Accompanying Venous Tumor Thrombi: Retrospective, Comparative, Monocentric Study in Treatment-Naive Patients
por: Mazdak, Mehrdad, et al.
Publicado: (2021)

Identification of a Novel Renal Metastasis Associated CpG-Based DNA Methylation Signature (RMAMS)
por: Serth, Jürgen, et al.
Publicado: (2022)

Reduced mrna expression level of corticotropin-releasing hormone-binding protein is associated with aggressive human kidney cancer
por: Tezval, Hossein, et al.
Publicado: (2013)

DNA Methylation Biomarkers Predict Progression-Free and Overall Survival of Metastatic Renal Cell Cancer (mRCC) Treated with Antiangiogenic Therapies
por: Peters, Inga, et al.
Publicado: (2014)

GATA5 CpG island hypermethylation is an independent predictor for poor clinical outcome in renal cell carcinoma
por: PETERS, INGA, et al.
Publicado: (2014)

Age-Related DNA Methylation in Normal Kidney Tissue Identifies Epigenetic Cancer Risk Susceptibility Loci in the ANKRD34B and ZIC1 Genes
por: Serth, Jürgen, et al.
Publicado: (2022)

Decreased GATA5 mRNA expression associates with CpG island methylation and shortened recurrence-free survival in clear cell renal cell carcinoma
por: Peters, Inga, et al.
Publicado: (2014)

Hsa-mir-124-3 CpG island methylation is associated with advanced tumours and disease recurrence of patients with clear cell renal cell carcinoma
por: Gebauer, K, et al.
Publicado: (2013)

RASSF1A protein expression and correlation with clinicopathological parameters in renal cell carcinoma
por: Tezval, Hossein, et al.
Publicado: (2008)

Combination of PI-RADS score and mRNA urine test—A novel scoring system for improved detection of prostate cancer
por: Katzendorn, Olga, et al.
Publicado: (2022)

Urocortin and corticotropin-releasing factor receptor 2 in human renal cell carcinoma: disruption of an endogenous inhibitor of angiogenesis and proliferation
por: Tezval, Hossein, et al.
Publicado: (2009)

RASSF1A promoter methylation and expression analysis in normal and neoplastic kidney indicates a role in early tumorigenesis
por: Peters, Inga, et al.
Publicado: (2007)

Hemopatch(®) as a Hemostatic Agent is Safe in Partial Nephrectomy: A Large, Single-Surgeon Retrospective Evaluation
por: Hupe, Marie C., et al.
Publicado: (2020)

Spider silk erectile nerve reconstruction in robot-assisted radical prostatectomy: a first-in-men feasibility analysis
por: Harke, Nina N., et al.
Publicado: (2023)

PD-L1 status and Immune checkpoint inhibitors in kidney cancer: ignorance, lack of knowledge or both
por: Tezval, Hossein, et al.
Publicado: (2021)

Galectin-1 and Galectin-3 mRNA expression in renal cell carcinoma
por: von Klot, Christoph-A, et al.
Publicado: (2014)

First experiences using transurethral ultrasound ablation (TULSA) as a promising focal approach to treat localized prostate cancer: a monocentric study
por: Peters, Inga, et al.
Publicado: (2023)

Caveolin 1 protein expression in renal cell carcinoma predicts survival
por: Steffens, Sandra, et al.
Publicado: (2011)

Cadherin-1 and cadherin-3 cooperation determines the aggressiveness of pancreatic ductal adenocarcinoma
por: Siret, Carole, et al.
Publicado: (2018)

Cadherin-9 Is a Novel Cell Surface Marker for the Heterogeneous Pool of Renal Fibroblasts
por: Thedieck, Cornelia, et al.
Publicado: (2007)

Clear-cell variant urothelial carcinoma of the bladder: a case report and review of the literature
por: Kramer, Mario W., et al.
Publicado: (2012)

Expression of Ksp-cadherin during kidney development and in renal cell carcinoma
por: Thedieck, C, et al.
Publicado: (2005)

Evaluation of MRI/Ultrasound Fusion-Guided Prostate Biopsy Using Transrectal and Transperineal Approaches
por: Tewes, Susanne, et al.
Publicado: (2017)

Olanzapine-induced methylation alters cadherin gene families and associated pathways implicated in psychosis
por: Melka, Melkaye G, et al.
Publicado: (2014)

Misregulated E-Cadherin Expression Associated with an Aggressive Brain Tumor Phenotype
por: Lewis-Tuffin, Laura J., et al.
Publicado: (2010)

Aberrant P-cadherin expression is associated to aggressive feline mammary carcinomas
por: Figueira, Ana Catarina, et al.
Publicado: (2014)

Incidence of synchronous and metachronous adrenal metastases following tumor nephrectomy in renal cell cancer patients: a retrospective bi-center analysis
por: Peters, Inga, et al.
Publicado: (2013)

Role of free testosterone levels in patients with metastatic castration-resistant prostate cancer receiving second-line therapy
por: von Klot, Christoph A., et al.
Publicado: (2017)

Fibronectin 1 mRNA expression correlates with advanced disease in renal cancer
por: Waalkes, Sandra, et al.
Publicado: (2010)

p53 immunohistochemistry as an independent prognostic factor for superficial transitional cell carcinoma of the bladder.
por: Serth, J., et al.
Publicado: (1995)

Aggression and Anxiety: Social Context and Neurobiological Links
por: Neumann, Inga D., et al.
Publicado: (2010)

SNAI1 is critical for the aggressiveness of prostate cancer cells with low E-cadherin
por: Deep, Gagan, et al.
Publicado: (2014)

Calgranulin A (S100A8) Immunostaining: A Future Candidate for Risk Assessment in Patients with Non-Muscle-Invasive Bladder Cancer (NMIBC)
por: Nicklas, André P., et al.
Publicado: (2018)

Anti-aggressive effects of neuropeptide S independent of anxiolysis in male rats
por: Beiderbeck, Daniela I., et al.
Publicado: (2014)

Distinct Mesenchymal Alterations in N-Cadherin and E-Cadherin Positive Primary Renal Epithelial Cells
por: Keller, Christof, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_57g7v6ff7h1vbu4d5h4lhlkmf2